Navigation Links
Velcade (Bortezomib) for Injection Based Therapies Produced,Complete Remission Rates as High as 54 Percent in Patients With,Previously Treated Multiple Myeloma

- 100 percent of patients treated with VELCADE, cyclophosphamide, and prednisone alive at one year -

KOS, Greece, June 28, 2007 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today reported on the presentation of results from clinical trials of VELCADE based therapies that showed high complete remission / complete response(1) (CR) rates in previously treated multiple myeloma (MM) patients. These findings were presented at the prestigious 11th International Myeloma Workshop (IMW) in Kos, Greece. Highlights included:

    


    -- VELCADE, cyclophosphamide and prednisone (VCP) demonstrated an overall

       response rate (ORR) of 93 percent including a CR(1) rate of 54 percent.

       At one year, 100 percent of patients were alive.

    -- VELCADE, lenalidomide and dexamethasone (VRD) showed an ORR of 68

       percent with a 5 percent CR(1) rate in a pilot study of heavily

       pretreated patients, including those who had been previously treated

       with VELCADE or lenalidomide.

"By combining the power of VELCADE with other active agents, we are seeing some of the strongest reported efficacy in previously treated multiple myeloma patients," said Nancy Simonian, M.D., Chief Medical Officer, Millennium. "The wealth of combination data that are being generated promises to strengthen the U.S. market-leading role of VELCADE."

Weekly VELCADE, Cyclophosphamide and Prednisone in Myeloma (Abstract #PO- 639)

"VELCADE has shown synergistic activity with alkylating agents by generating substantially high and durable complete remission rates," said Donna Reece, M.D., Princess Margaret Hospital. "This is an important finding for the field of multiple myeloma and leads us to believe that the combination of VELCADE and cyclophosphamide warrants further investigation in the front-line setting with the goal of prolonging patients' survival."

The Phase II study was d
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
3. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:2/27/2015)... , Feb. 27, 2015  Pomerantz LLP is investigating ... ("Vitae" or the "Company") (NASDAQ: VTAE ).  ... Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. ... certain of its officers and/or directors have violated Sections ... 1934.  On February 27, 2015, the ...
(Date:2/27/2015)... Securities lawyers at Dunnam & Dunnam ... (NASDAQ: SLXP ) in connection with a ... are encouraged to contact attorney Hamilton Lindley by ... upon the shareholder value of the transaction. Under terms ... $158.00 per share in cash. At least one analyst ...
(Date:2/27/2015)... 2015 Report Details   ... trends, R&D progress, and predicted revenues ,Where is the ... the commercial prospects for this market and related technologies? ... other trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... Pharmos Corporation (OTC-PINK: PARS) today reported financial results for ... These results are included in the Company,s Quarterly Report on ... Second Quarter Ended June 30, 2011The Company recorded ... for the second quarter 2011 compared to a net loss ...
... Md., Aug. 8, 2011 /PRNewswire-Asia/ -- Chindex International, Inc. ... company providing health care services in China through the operations ... hospitals and affiliated ambulatory clinics, today announced financial results for ... 30, 2011. Second Quarter 2011 ...
Cached Medicine Technology:Pharmos Corporation Reports 2011 Second Quarter Results 2Pharmos Corporation Reports 2011 Second Quarter Results 3Pharmos Corporation Reports 2011 Second Quarter Results 4Pharmos Corporation Reports 2011 Second Quarter Results 5Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 2Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 3Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 4Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 5Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 6Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 7Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 8Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 9Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 10Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2011 11
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people to ... thinking. “The #1 block was lack of time ... Haman, who created the Thinkubator Innovation Studio in Chicago. ... they did not have enough time for innovative thinking ... innovation. , Solutionman’s monthly “Accelerating Innovation Training” workshops address ...
(Date:2/28/2015)... Morristown, NJ (PRWEB) February 28, 2015 ... Month—is a good time to remind ourselves and ... be ignored, say Atlantic NeuroSurgical Specialists (ANS). , ... (TBI), which account for 75% of TBIs. There ... word concussion may sound benign, but it is ...
(Date:2/28/2015)... 2015 A study out of the ... therapy procedure for the treatment of a hereditary ocular ... Authored by Dr. Robert MacLaren, professor of ophthalmology ... Lancet Medical Journal on January 16, 2014 , the ... genetic disorder that mostly affects men and leads to ...
(Date:2/28/2015)... Louis, MO (PRWEB) February 28, 2015 ... leading provider of outsourced sales, marketing and supply ... their client, BIOTA Botanicals, is bringing its award ... Celebrated worldwide, BIOTA Botanicals’ products are specifically created ... herbal care experts, BIOTA is committed to marrying ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at ... and current student obtaining her Masters degree in social ... forum in psychoeducation on substance use for teens at ... part of her studies. , “Even though these students ... counseling at the high school and junior high school ...
Breaking Medicine News(10 mins):Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... through abstract cases more likely to retain knowledge, study ... use of "real-world" concrete examples doesn,t help students learn ... challenges the widespread use of this approach in classrooms. ... learned a mathematical concept with concrete examples couldn,t apply ...
... opportunities for ... individuals age 50 and above, PITTSBURGH, April 24 ... career Web site for job seekers age 50 and above. Highmark,received ... first plan in the Blue Cross Blue Shield network to earn ...
... Werth to Lead Expansion of Organization,s DC-Based Legislative,Initiatives, ... Relations and Public Policy department announced today the,appointment ... of Federal,Government Relations position. Based in the organization,s ... Oncology,s reach on Capitol Hill,in order to advance ...
... 22nd Acquisition for The Huron Fund II L.P., ... announced,today that its portfolio company Michigan Orthopedic Services ... ("Koch,s"). Terms of,the transaction were not disclosed. The ... partnered with CEO Aziz Naser to recapitalize MOS. ...
... Strike Force, WASHINGTON, April 24 A federal jury ... role in a $3 million,Medicare fraud scheme and for money ... and U.S. Attorney R. Alexander,Acosta of the Southern District of ... Miami, the jury found Gustavo Smith, 43,guilty of all 17 ...
... Denise Austin Team Up to Inspire Americans, ORRVILLE, ... Company, makers of Smucker,s(R) fruit spreads and Smucker,s(R),Natural Peanut ... You Tour,which emphasizes the importance of a balanced diet ... both areas can make a big difference,throughout each day. ...
Cached Medicine News:Health News:'Real World' Examples Don't Make Math Any Easier 2Health News:Highmark Inc. Named an Age-Friendly Employer by RetirementJobs.com 2Health News:Highmark Inc. Named an Age-Friendly Employer by RetirementJobs.com 3Health News:US Oncology Welcomes New Director of Federal Government Relations 2Health News:Huron Capital Moves Quickly To Expand O&P Business 2Health News:Miami Jury Convicts Pharmacy Owner of Medicare Fraud 2Health News:The J.M. Smucker Company Travels the U.S. to Launch the Simple Steps To A Better You Campaign 2Health News:The J.M. Smucker Company Travels the U.S. to Launch the Simple Steps To A Better You Campaign 3Health News:The J.M. Smucker Company Travels the U.S. to Launch the Simple Steps To A Better You Campaign 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: